RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)

6 Months Ended

Jun. 30, 2025

Accounting Changes and Error Corrections [Abstract]

Schedule of Revision of Previously Issued Financial Statements

The following tables present the impact of the restatement on the affected line items of the Company’s previously issued condensed consolidated financial statements (in thousands, except per share amounts):

Condensed Consolidated Balance Sheets

	June 30, 2025 (Unaudited)
	As Reported		Adjustment		As Restated
Assets
Property, plant and equipment, net	$	828,603	$	(127,311)	$	701,292
Total Assets	1,978,052		(127,311)		1,850,741
Liabilities and Stockholders’ Deficit
Stockholders’ Deficit:
Accumulated deficit	(4,091,324)		(127,311)		(4,218,635)
Total Stockholders’ Deficit	(1,064,676)		(127,311)		(1,191,987)
Total Liabilities and Stockholders’ Deficit	$	1,978,052	$	(127,311)	$	1,850,741

Condensed Consolidated Statements of Operations

	For the Six Months Ended June 30, 2025
	As Reported		Adjustment		As Restated
	(Unaudited)				(Unaudited)
Selling, general and administrative	$	97,055	$	4,442	$	101,497
Operating loss	(68,880)		(4,442)		(73,322)
Loss before income taxes	(355,743)		(4,442)		(360,185)
Net loss	$	(356,106)	$	(4,442)	$	(360,548)
Net loss per share, basic and diluted	$	(0.21)	$	(0.02)	$	(0.23)

Condensed Consolidated Statements of Cash Flows

	For the Six Months Ended June 30, 2025
	As Reported		Adjustment		As Restated
	(Unaudited)				(Unaudited)
Cash flows from Operating Activities:
Net loss	(356,106)		(4,442)		(360,548)
Net cash (used in) provided by operating activities	$	(6,599)	$	(4,442)	(11,041)
Cash flows from Investing Activities:
Purchases of property, plant and equipment	(209,701)		4,442		(205,259)
Net cash used in investing activities	$	(213,066)	$	4,442	(208,624)